The College of American Pathologists (CAP) hosted its final media briefing of 2021 featuring leading pathologists—the physicians who biopsy and diagnose disease. As the COVID-19 pandemic is well into its second full year, experts tackled the continued challenges of COVID-19 testing, the emergence of new variants, international testing mandates, the importance of vaccines, boosters, hospital staffing shortages both in and outside the laboratory, and guarding against medical misinformation. Pathologists discussed a dramatic rise in the number of cancer diagnoses and severity of those cancers in the U-S population, a change in the way pathologists test for kidney disease so as to eliminate racial inequity, and the severe shortage of forensic pathologists.
Educate your audiences on:
- The current state of testing and the continued importance of accurate testing in 2022.
- Omicron and Delta variants and their impact
- Education on the at-home and rapid testing
- Importance to "test right"
- Hospital staffing shortages and the impact on testing turnaround times
- Increase in the diagnosis and severity of cancers and other diseases
- This is happening because patients are delaying routine care
- What steps people can take to stop this
- New changes to take racial bias out of testing for kidney disease
- The shortage of forensic pathologists and how this is overwhelming the death investigation system
| Moderator/Panelist: | Emily E. Volk, MD, FCAP |
| Panelists: | Sue Chang, MD, FCAP Amy Karger, MD, FCAP James Gill, MD, FCAP |
